OPTHF - Optimi To Supply Psilocybin For New Zealand's M?tai Medical Research Institute | Benzinga
Canadian licensed psychedelics pharmaceutical manufacturer Optimi Health Corp. (OTCQX:OPTHF) has signed an international agreement to supply natural psilocybin to New Zealand-based M?tai Medical Research Institute, on behalf of the T? Wairua Project.
The agreement marks Optimi’s first supply deal involving Kiwiland, and "a significant milestone" for the company’s global expansion efforts.
The company will provide M?tai with its GMP Full Spectrum Natural Psilocybin extract, and further track stability of the extract toward ensuring the highest standards of GMP quality and compliance.
Join us at our upcoming Benzinga Cannabis Capital Conference!
Zealand Endeavor
November 2023, the individuals, wh?nau (families), community groups and institutions that make up the T? Wairua project gathered at Rangiwaho Marae, a tribal meeting place in New Zealand's Tair?whiti region.
The project team has since designed a clinical ...